Cargando…
A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
The cleavage reactions of catalytic antibodies are mediated by a serine protease mechanism involving a catalytic triad composed of His, Ser, and Asp residues, which reside in the variable region. Recently, we discovered a catalytic antibody, H34 wild type (H34wt), that is capable of enzymatically cl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649737/ https://www.ncbi.nlm.nih.gov/pubmed/36357546 http://dx.doi.org/10.1038/s41598-022-23689-6 |
_version_ | 1784827862475341824 |
---|---|
author | Hifumi, Emi Nonaka, Tamami Taguchi, Hiroaki Uda, Taizo |
author_facet | Hifumi, Emi Nonaka, Tamami Taguchi, Hiroaki Uda, Taizo |
author_sort | Hifumi, Emi |
collection | PubMed |
description | The cleavage reactions of catalytic antibodies are mediated by a serine protease mechanism involving a catalytic triad composed of His, Ser, and Asp residues, which reside in the variable region. Recently, we discovered a catalytic antibody, H34 wild type (H34wt), that is capable of enzymatically cleaving an immune-check point PD-1 peptide and recombinant PD-1; however, H34wt does not contain His residues in the variable region. To clarify the reason behind the catalytic features of H34wt and the amino acid residues involved in the catalytic reaction, we performed site-directed mutagenesis focusing on the amino acid residues involved in the cleavage reaction, followed by catalytic activity tests, immunological reactivity evaluation, and molecular modeling. The results revealed that the cleavage reaction by H34wt proceeds through the action of a new catalytic site composed of Arg, Thr, and Gln. This new scheme differs from that of the serine protease mechanism of catalytic antibodies. |
format | Online Article Text |
id | pubmed-9649737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96497372022-11-15 A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain Hifumi, Emi Nonaka, Tamami Taguchi, Hiroaki Uda, Taizo Sci Rep Article The cleavage reactions of catalytic antibodies are mediated by a serine protease mechanism involving a catalytic triad composed of His, Ser, and Asp residues, which reside in the variable region. Recently, we discovered a catalytic antibody, H34 wild type (H34wt), that is capable of enzymatically cleaving an immune-check point PD-1 peptide and recombinant PD-1; however, H34wt does not contain His residues in the variable region. To clarify the reason behind the catalytic features of H34wt and the amino acid residues involved in the catalytic reaction, we performed site-directed mutagenesis focusing on the amino acid residues involved in the cleavage reaction, followed by catalytic activity tests, immunological reactivity evaluation, and molecular modeling. The results revealed that the cleavage reaction by H34wt proceeds through the action of a new catalytic site composed of Arg, Thr, and Gln. This new scheme differs from that of the serine protease mechanism of catalytic antibodies. Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9649737/ /pubmed/36357546 http://dx.doi.org/10.1038/s41598-022-23689-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hifumi, Emi Nonaka, Tamami Taguchi, Hiroaki Uda, Taizo A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain |
title | A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain |
title_full | A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain |
title_fullStr | A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain |
title_full_unstemmed | A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain |
title_short | A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain |
title_sort | new catalytic site functioning in antigen cleavage by h34 catalytic antibody light chain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649737/ https://www.ncbi.nlm.nih.gov/pubmed/36357546 http://dx.doi.org/10.1038/s41598-022-23689-6 |
work_keys_str_mv | AT hifumiemi anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT nonakatamami anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT taguchihiroaki anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT udataizo anewcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT hifumiemi newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT nonakatamami newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT taguchihiroaki newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain AT udataizo newcatalyticsitefunctioninginantigencleavagebyh34catalyticantibodylightchain |